Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
3(43%)
Results Posted
0%(0 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
5
71%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Recruiting3
Terminated2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

terminated229%
completed114%
recruiting343%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7